Bevacizumab for advanced ovarian cancer treatment. A GRADE based approach
<p><strong>Background: </strong>in advanced ovarian cancer, over the last 10 years no studies have demonstrated more appropriate therapeutic options compared to the current standard Carboplatin-Paclitaxel (Cb-P) regimen. Two phase III randomized studies (GOG-218 36 and ICON-7 37) h...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Milano University Press
2013-03-01
|
| Series: | Epidemiology, Biostatistics and Public Health |
| Online Access: | http://ebph.it/article/view/8826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|